Peter Attia· MD
and all of those endpoints have published their analysis of those secondary endpoints and have one of the main side effects of you know fiber not a heck of a lot you know it's a pretty well tolerated drug
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and all of those endpoints have published their analysis of those secondary endpoints and have one of the main side effects of you know fiber not a heck of a lot you know it's a pretty well tolerated drug
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.